Company profile: VaLogic
1.1 - Company Overview
Company description
- Provider of facility management solutions for pharma, biotech, and life sciences, delivering GxP compliance services (calibration, commissioning, qualification, validation, environmental monitoring), CQV, GMP environmental monitoring (air, surface, water, lab gases), cleanroom and biosafety cabinet certification, comprehensive calibration, and the LogiPoint continuous monitoring system for critical environments and equipment.
Products and services
- LogiPoint Facility Monitoring System: An industrial-grade continuous monitoring system for critical environments and equipment, delivering real-time temperature, humidity, and pressure data to safeguard controlled conditions
- GxP Compliance: GxP-compliant services delivering calibration, commissioning, qualification, validation, and environmental monitoring to ensure compliance in pharmaceuticals, biotechnology, and life sciences facilities
- CQV Services: Industry-standard CQV services encompassing Commissioning, Qualification, and Validation for facilities and equipment, confirming they meet standards and perform as expected
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to VaLogic
Galenicum
HQ: Spain
Website
- Description: Provider of pharmaceutical products and services, including R&D, regulatory affairs, manufacturing, licensing, and global supply across technologies from injectables to oral solids and nasal sprays. Operates a facility near Madrid producing over 50 million packs annually, trades APIs, and markets Vitae bioequivalent medicines and Galenicum Derma specialty dermatology products; applies QbD standards in development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Galenicum company profile →
Natural Pharmaceuticals
HQ: Poland
Website
- Description: Provider of science- and technology-driven health offerings focused on the Omega-3 segment; a Norwegian market leader dedicated to raising awareness among Central European consumers of the health benefits of diets rich in fish and marine fatty acids.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Natural Pharmaceuticals company profile →
Rhenovia
HQ: France
Website
- Description: Provider of applications of biosimulation rooted in neuroscience and nervous system modeling, from a French biotechnology company founded in 2007 by managers from large pharmaceutical companies and world experts.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Rhenovia company profile →
Resolian
HQ: United States
Website
- Description: Provider of multinational bioanalytical CRO services focused on medication metabolism and pharmacokinetics for small and big compounds.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Resolian company profile →
Berkshire Sterile Manufacturing
HQ: United States
Website
- Description: Provider of small-scale sterile manufacturing services for clinical use, delivering the safest sterile drug products with the highest level of sterility assurance and quality through modern sterile manufacturing technologies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Berkshire Sterile Manufacturing company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for VaLogic
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to VaLogic
2.2 - Growth funds investing in similar companies to VaLogic
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for VaLogic
4.2 - Public trading comparable groups for VaLogic
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →